ALC Earnings Date: Nov 10, 2026 (Estimated) — Alcon Inc.
NYSE · Healthcare · Medical Instruments & Supplies
Updated
When is ALC's next earnings date?
Alcon Inc. (ALC) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.89 on revenue of $2.68B.
How did ALC do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Alcon Inc. posted EPS of $0.84 versus the $0.77 estimate, a beat of 10.5%. Revenue was $2.78B against a $2.72B estimate. The stock's 1-day post-earnings move was +2.3%.
How much does ALC stock move after earnings?
ALC beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.4% (up or down) in the day after earnings.
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | 0.77 | 0.84 | +10.53% | $2.78B | ✅ Beat | +2.34% | -1.55% | -7.06% |
| 2026-05-07 | Q1 2026 | 0.80 | 0.05 | -93.75% | $127.8M | ❌ Miss | -2.34% | -3.01% | +2.14% |
| 2026-02-24 | Q4 2025 | 0.84 | 0.78 | -7.14% | $2.70B | ❌ Miss | +2.54% | -1.25% | -10.54% |
| 2025-11-11 | Q3 2025 | 0.82 | 0.79 | -3.66% | $2.59B | ❌ Miss | +2.68% | -2.05% | +1.80% |
| 2025-08-19 | Q2 2025 | 0.72 | 0.76 | +5.56% | $2.58B | ✅ Beat | -10.07% | -9.62% | -13.68% |
| 2025-02-25 | Q4 2024 | 0.71 | 0.72 | +1.41% | $2.48B | ✅ Beat | +2.41% | +1.62% | +0.22% |
| 2024-08-20 | Q2 2024 | 0.73 | 0.74 | +1.37% | $2.48B | ✅ Beat | -1.95% | -0.46% | +1.90% |
| 2024-05-13 | Q1 2024 | 0.72 | 0.78 | +8.33% | $2.44B | ✅ Beat | +10.57% | +9.10% | +14.26% |
Showing last 8 quarters.